Allurion to effect 1-for-25 reverse stock split on Jan 3, 2025 to cure NYSE bid price deficiency

ALLURION TECHNOLOGIES, INC.

Outstanding shares reduced from ~67.78M to ~2.71M; effective 12:01 a.m. ET Jan 3, 2025.
CUSIP number changes to 02008G 201; trading symbol ALUR remains unchanged.
Each public warrant (ALUR WS) becomes exercisable for 0.056818 shares at $202.50 per share.
Company received NYSE deficiency letter on Aug 12, 2024 due to bid price below $1.00 for 30 days.
No fractional shares issued; fractional holders automatically rounded up to next whole share.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ALLURION TECHNOLOGIES, INC.: Approved and filed a charter amendment to effect a 1-for-25 reverse stock split, effective January 3, 2025 (effective 2025-01-03).

Change: charter amendment
Effective: 2025-01-03

Exact text from the filing

Effective as of 12:01 a.m. Eastern Time on January 3, 2025, the Company filed an amendment (the "Certificate of Amendment") to its Amended and Restated Certificate of Incorporation, as amended and/or restated from time to time, to effectuate the Reverse Stock Split.

View on SEC.gov

Browse all governance changes →

ALLURION TECHNOLOGIES, INC. filing history →

Source: SEC EDGAR

accession 0001193125-24-287091

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.